Paper Details

  1. Home
  2. Paper Details

Outcomes from switching from rotigotine patch to alternate therapies in Parkinson's disease.

Author: ChitnisShilpa, DeweyRichard B, JafferyManall

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

Rotigotine was an effective treatment for Parkinson's disease, with patients experiencing a decline in efficacy and side effects after switching to alternate therapies, except for the levodopa group.
Paper Details　
Original Abstract of the Article :
BACKGROUND: When rotigotine patch was withdrawn from the US market, we prospectively gathered data on efficacy, side effects, and daytime sedation on patients while taking rotigotine and following the switch to alternate therapies. METHODS: Patients rated the efficacy of rotigotine on a scale of 0-...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3109/00207454.2011.617016

データ提供：米国国立医学図書館（NLM）

Outcomes of Switching from Rotigotine Patch to Alternate Therapies

This study investigates the outcomes of switching from rotigotine patch, a medication used to treat Parkinson's disease, to alternate therapies. The authors prospectively gathered data on efficacy, side effects, and daytime sedation in patients who had to switch due to the withdrawal of rotigotine from the US market.

Challenges in Switching Parkinson's Medications

The study found that switching from rotigotine to alternate therapies often resulted in a decrease in efficacy and an increase in side effects. The authors emphasize the importance of careful consideration and individualized treatment plans when switching medications for Parkinson's disease.

Managing Parkinson's Disease

This research provides valuable insights into the challenges associated with managing Parkinson's disease. It highlights the importance of finding the right medication and treatment regimen for each patient, as well as the need for ongoing monitoring and adjustments.

Dr. Camel's Conclusion

Navigating the complexities of Parkinson's disease can feel like traversing a shifting desert landscape. This study underscores the importance of careful medication management and individualized treatment plans. Finding the right approach can make a significant difference in the lives of those living with this chronic condition.

Date :
  1. Date Completed 2012-08-21
  2. Date Revised 2017-11-16
Further Info :

Pubmed ID

21864207

DOI: Digital Object Identifier

10.3109/00207454.2011.617016

Related Literature

Article Analysis
・Side Effects of rasagiline
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.